Cargando…
Activin B is a novel biomarker for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) diagnosis: a cross sectional study
BACKGROUND: Investigations of activin family proteins as serum biomarkers for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME). CFS/ME is a disease with complex, wide-ranging symptoms, featuring persistent fatigue of 6 months or longer, particularly post exertion. No definitive biomarkers...
Autores principales: | Lidbury, Brett A., Kita, Badia, Lewis, Donald P., Hayward, Susan, Ludlow, Helen, Hedger, Mark P., de Kretser, David M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5353946/ https://www.ncbi.nlm.nih.gov/pubmed/28302133 http://dx.doi.org/10.1186/s12967-017-1161-4 |
Ejemplares similares
-
Rethinking ME/CFS Diagnostic Reference Intervals via Machine Learning, and the Utility of Activin B for Defining Symptom Severity
por: Lidbury, Brett A., et al.
Publicado: (2019) -
Weighting of orthostatic intolerance time measurements with standing difficulty score stratifies ME/CFS symptom severity and analyte detection
por: Richardson, Alice M., et al.
Publicado: (2018) -
Potential of Activin B as a Clinical Biomarker in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
por: Gravelsina, Sabine, et al.
Publicado: (2021) -
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): An Overview
por: Deumer, Undine-Sophie, et al.
Publicado: (2021) -
Immunosignature Analysis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
por: Günther, Oliver P., et al.
Publicado: (2018)